Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes
Sign Up to like & getrecommendations! Published in 2017 at "Diabetologia"
DOI: 10.1007/s00125-017-4388-y
Abstract: Aims/hypothesisThe main aims of the present study were: (1) to assess the expression and content of dipeptidyl peptidase IV (DPP-IV) in human and db/db mouse retinas, and in human vitreous fluid; and (2) to determine… read more here.
Keywords: topical administration; glp; neurodegeneration; dpp ... See more keywords